Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer (vol 131, pg 23, 2024)

초록

Correction to: British Journal of Cancerhttps://doi.org/10.1038/s41416-024-02698-4, published online 10 May 2024 Following the publication of the article, the authors identified typographical errors within some of the correlation plots presented, stemming from having used the ‘slope value of graph’ rather than ‘coefficient Rho value’ from the statistical analyses results. The areas affected are: Fig 5G: CTL signature / High PD-L1 Fig 6B: Vim H-score / PD Fig 6C: CD8 / PD (E-cad H-score), and CD8 / PD (Twist1 H-score) Supplemental Fig 11A: CD8 / CR+PR (E-cad H-score), and CD8 / CR+PR (Twist1 H-score) Fig 5G: CTL signature / High PD-L1 Fig 6B: Vim H-score / PD Fig 6C: CD8 / PD (E-cad H-score), and CD8 / PD (Twist1 H-score) Supplemental Fig 11A: CD8 / CR+PR (E-cad H-score), and CD8 / CR+PR (Twist1 H-score) There has been no change to the raw data presented; the changes do not impact the scientific interpretation of the relevant results. The original article has been corrected. © The Author(s) 2024.